| Title |
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician
|
|---|---|
| Published in |
European Journal of Nuclear Medicine and Molecular Imaging, April 2017
|
| DOI | 10.1007/s00259-017-3695-3 |
| Pubmed ID | |
| Authors |
S. Lheureux, C. Denoyelle, P. S. Ohashi, J. S. De Bono, F. M. Mottaghy |
| Abstract |
Molecular imaging continues to influence every aspect of cancer care including detection, diagnosis, staging and therapy response assessment. Recent advances in the understanding of cancer biology have prompted the introduction of new targeted therapy approaches. Precision medicine in oncology has led to rapid advances and novel approaches optimizing the use of imaging modalities in cancer care, research and development. This article focuses on the concept of targeted therapy in cancer and the challenges that exist for molecular imaging in cancer care. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 115 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 115 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 21 | 18% |
| Student > Bachelor | 18 | 16% |
| Student > Master | 17 | 15% |
| Researcher | 10 | 9% |
| Professor | 4 | 3% |
| Other | 17 | 15% |
| Unknown | 28 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 20 | 17% |
| Biochemistry, Genetics and Molecular Biology | 19 | 17% |
| Chemistry | 12 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 10% |
| Agricultural and Biological Sciences | 4 | 3% |
| Other | 17 | 15% |
| Unknown | 32 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 November 2018.
All research outputs
#2,983,664
of 23,806,312 outputs
Outputs from European Journal of Nuclear Medicine and Molecular Imaging
#267
of 3,083 outputs
Outputs of similar age
#55,221
of 311,559 outputs
Outputs of similar age from European Journal of Nuclear Medicine and Molecular Imaging
#6
of 44 outputs
Altmetric has tracked 23,806,312 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,083 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 311,559 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.